Rebamipide, novel prostaglandin-inducer, accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer comparison with cimetidine

@article{Arakawa2005RebamipideNP,
  title={Rebamipide, novel prostaglandin-inducer, accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer comparison with cimetidine},
  author={Tetsuo Arakawa and Toshio Watanabe and Takashi Fukuda and Katsuya Yamasaki and Kenzo Kobayashi},
  journal={Digestive Diseases and Sciences},
  year={2005},
  volume={40},
  pages={2469-2472}
}
This study was done to elucidate whether rebamipide during the initial period of acetic acid-induced gastric ulcer affected healing and future ulcer relapse. The cumulative healing rate was higher in rats given rebamipide alone or those given rebamipide and cimetidine during and after administration, but not in rats given cimetidine alone, compared to control rats. Cumulative relapse rate was significantly lower in rats initially given rebamipide alone or those given rebamipide and cimetidine… 
Indomethacin treatment during initial period of acetic acid-induced rat gastric ulcer healing promotes persistent polymorphonuclear cell-infiltration and increases future ulcer recurrence
TLDR
The administration of indomethacin during the initial period of the ulcer healing promoted persistent polymorphonuclear cell infiltration and increased ulcer recurrence rates, possibly via a prostaglandin-dependent mechanism.
Effect of Rebamipide on Acetic Acid-induced Gastric Ulcer in Rats: Involvement of Hepatocyte Growth Factor
TLDR
The study suggests that rebamipide has anti-ulcerative effects on gastric mucosal cells via up-regulation of HGF, c-met, Cox-2 andEP2 and EP2.
Rebamipide Prevents Delay of Acetic Acid-Induced Gastric Ulcer Healing Caused by Helicobacter pylori Infection in Mongolian Gerbils
TLDR
In conclusion, rebamipide may prevent the delay of acetic acid-induced gastric ulcer healing caused by H. pylori through modulating cell kinetics and inhibiting neutrophil infiltration.
Rebamipide Reduces Recurrence of Experimental Gastric Ulcers: Role of Free Radicals and Neutrophils
TLDR
Results suggest that lipid peroxidation of gastric tissue mediated by free radicals from neutrophils is responsible for the recurrence of acetic acid-induced gastric ulcers in rats, and that the elimination of free radicals by rebamipide may contribute to the reduction of severity in ulcer recurrence.
Rebamipide Reduces Delay in Gastric Ulcer Healing in Cyclooxygenase-2-Deficient Mice
TLDR
The effect of rebamipide on the enhancement of ulcer healing, angiogenesis, and induction of bFGF expression was more prominent in wild-type mice than in COX-2-deficient mice.
High quality of ulcer healing in rats by lafutidine, a new-type histamine H2-receptor antagonist: involvement of capsaicin-sensitive sensory neurons
TLDR
In conclusion, the low recurrence rate of ulcers after lafutidine treatment in rats seems to depend on the gastroprotective mechanisms involving CSSN.
Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs
TLDR
It is suggested that rebamipide does not affect the direct irritating action of alendronate in the gastric mucosa, but this agent antagonizes the healing impairment action ofAlendronates by counteracting the downregulation of bFGF expression in the ulcerated mucosa.
An overview of acetic acid ulcer models--the history and state of the art of peptic ulcer research.
TLDR
It is concluded that acetic acid ulcer models are quite useful for various studies related to peptic ulcers.
Rebamipide Attenuates Indomethacin-Induced Gastric Mucosal Lesion Formation by Inhibiting Activation of Leukocytes in Rats
TLDR
Rebamipide may prevent indomethacin-induced gastric mucosal lesionformation by inhibiting neutrophil activation by inhibite neutrophils activation, unlike cimetidine.
Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase
TLDR
The results suggest that the suppressive effect of rebamipide on non-steroidal anti-inflammatory drugs-induced gastric mucosal injury can be attributed to reduced 15-hydroxyprostaglandin dehydrogenase expression, which increases the prostaglandsin E2 concentration in the gastric tissue.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 15 REFERENCES
Gastric mucosal resistance and prostanoid levels after cimetidine treatment in rats.
TLDR
The increase in gastric mucosal vulnerability observed 24 h after the last cimetidine injection might be related to a decrease in the prostanoid content and recovery of acid secretion, and the level had returned to normal 5 days later.
A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing.
TLDR
The studies of the healing process of the produced ulcer and the usefulness for the assay method of the curative drugs of gastric ulcer are dealt with.
Duodenal mucosa synthesis of prostaglandins in duodenal ulcer disease.
TLDR
There is a defect in the ability of the human duodenal mucosa in duodental ulcer disease to synthesise PGF2 alpha and PGI2; the defect is not limited to the ulcer site.
Prostanoid synthesis by cultured gastric and duodenal mucosa: Possible role in the pathogenesis of duodenal ulcer.
TLDR
Results suggest that a decrease in endogenous gastric prostanoid synthesis may have a role in the pathogenesis of peptic ulcer disease.
Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
TLDR
Subjects treated with cimetidine on a short-term basis relapsed earlier than those treated with sucralfate at 12 weeks, but at 1 year, the relapse rates were about 70% for both groups.
Deficiency of endogenous prostanoids in gastric and duodenal ulcer diseases
TLDR
Lower levels of PGE2 in patients with antral or duodenal ulcer and of P GE2 and PGF1α in patientswith corpus ulcer in the anatomical mucosal area including the ulcer site may predispose the mucosa to ulceration.
Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol.
TLDR
It is indicated that the gastric and duodenal mucosa is capable of generating PGE2-like activity which may be involved in the mechanism that protects the mucosa against the damage caused by aspirin.
Experimental studies on gastric ulcer. (4). Sequential observation and evaluation of gastric ulcers by endoscope in the rat.
TLDR
By this observation method, it is possible to observe repeatedly over a long term the changes in gastric lesions or ulcers, to measure changes in ulcer-sizes and to evaluate the relapse or recurrence of ulcers in the same rats.
...
1
2
...